AIM ImmunoTech Inc.

AIM · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 21 employees
373
SEC Filings
$0.2229
Close 2026-09-14
21
Employees

Business Summary

AIM ImmunoTech Inc. is an immuno-pharma company headquartered in Ocala, Florida, focused on research and development of therapeutics for cancers, viral diseases, and immune-deficiency disorders. Its flagship product, Ampligen (rintatolimod), is a double-stranded RNA molecule in development for pancreatic cancer, ME/CFS, Post-COVID conditions, and antiviral applications. Alferon N Injection (Interferon alfa) is its second product. Ampligen is FDA-unapproved in the U.S. but commercially approved in Argentina for severe Chronic Fatigue Syndrome.

Latest Stock Quote

AIM 2026-09-14 $0.2229 O:$0.2121 H:$0.2229 L:$0.211 Vol:1.7M VWAP:$0.215
origin leaf: null

Next Earnings

expected 2026-11-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001493152-26-013301EDGAR84K words
2025-03-272024-12-310001641172-25-000847EDGAR79K words
2024-04-012023-12-310001493152-24-012058EDGAR72K words
2023-03-312022-12-310001493152-23-010351EDGAR—
2022-03-312021-12-310001493152-22-008324EDGAR—
2021-03-312020-12-310001493152-21-007259EDGAR—
2020-03-302019-12-310001493152-20-005290EDGAR—
2019-04-012018-12-310001493152-19-004583EDGAR—
2018-03-302017-12-310001493152-18-004291EDGAR—
2017-03-312016-12-310001493152-17-003242EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001493152-26-036609EDGAR41K words
2025-11-172025-09-300001493152-25-023894EDGAR37K words
2025-08-142025-06-300001493152-25-011986EDGAR35K words
2025-05-152025-03-310001641172-25-011033EDGAR32K words
2024-11-142024-09-300001493152-24-045971EDGAR38K words
2024-08-142024-06-300001493152-24-032355EDGAR35K words
2024-05-152024-03-310001493152-24-019917EDGAR27K words
2023-11-142023-09-300001493152-23-041294EDGAR32K words
2023-08-142023-06-300001493152-23-028610EDGAR—
2023-05-152023-03-310001493152-23-016763EDGAR—
2022-11-142022-09-300001493152-22-032118EDGAR—
2022-08-152022-06-300001493152-22-022600EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-140001493152-26-042592EDGAR1K words
2026-09-100001493152-26-042196EDGAR1K words
2026-09-040001493152-26-041537EDGAR1K words
2026-08-110001493152-26-036996EDGAR1K words
2026-08-100001493152-26-036753EDGAR1K words
2026-08-060001493152-26-036408EDGAR5K words
2026-08-050001493152-26-036104EDGAR1K words
2026-07-160001493152-26-033514EDGAR1K words
2026-03-060001493152-26-009190EDGAR21K words
2026-02-050001493152-26-005208EDGAR1K words

373 total filings indexed. 341 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE ABPO — Abpro Holdings, Inc.

Tags

oncology-(pancreatic-cancer,-ovarian-cancer,-solid-tumors) viral-diseases-(covid-19,-avian-influenza,-sars) immune-deficiency-disorders-(me/cfs,-post-covid-conditions) double-stranded-rna-(dsrna)-molecule-technology checkpoint-inhibitor-combination-therapy intranasal-vaccine-adjuvant-delivery

Company Identity

CIK0000946644
TickerAIM
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
HeadquartersOcala, Florida
Websitehttps://www.aimimmuno.com
Listed1995-11-02

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: c42a9bfae7778b953785b47982253088b84d5be4789c34b1ace3b9b432d58f5f
parent: f20e4757f9cab602bfd6a481b56f6b7e630cd490207876322aa6861870fa1d68
content hash: 663df02238ea7c646506b29b60fea1c7278f1e0aeb0718e36663ead96bb1adbd
signed: 2026-09-27T19:00:10.566Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AIM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AIM, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AIM (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.